1Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation [ J]. JAMA, 2001,285 ( 22 ) : 2864 -2870. 被引量：1
2Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation[ J ]. Chest, 2010,137 (2) : 263-272. DOI: 10. 1378/chest. 09-1584. 被引量：1
3Olesen JB, Torp-Pedersen C, Hansen ML, et al. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study [ J ]. Thromb Haemost, 2012,107 (6) : 1172-1179. DOI : 10.1160/TH12-03-0175. 被引量：1
4Oldgren J, Healey JS, Ezekowitz M, et al. Variations in etiology and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY AF registry [ J ]. Circulation, 2014, 129 ( 15 ) : 1568-1576. DOI: 10. 1161/CIRCULATIONAHA. 113. 005451. 被引量：1
5Pisters R, Lane DA, Nieuwlaat Pt, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey [J]. Chest,2010,138 ( 5 ) : 1093-1100. DOI : 10.1378/chest. 10-0134. 被引量：1
